Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2014-03-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于公司2013年度募集资金存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2013年度募集资金存放与使用情况鉴证报告" which translates to "2013 Annual Verification Report on the Storage and Use of Raised Funds". It is issued by an accounting firm (立信会计师事务所) and includes an independent verification opinion on the company's special report about the storage and actual use of raised funds for the year 2013. The document references regulatory guidelines from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, and it details the amounts raised, usage, balances, and changes in investment projects related to the raised funds. The document is a standalone audit/verification report focusing on the use of capital raised by the company, not a full annual report or interim financial report. It does not contain comprehensive financial statements or management discussion of overall company performance, but rather a specific audit opinion on the use of raised funds. Therefore, it fits the category of an Audit Report / Information (AR). The document length (over 10,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification letter. Hence, the classification is AR with high confidence. FY 2013
2014-03-27 Chinese
2013年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2013年度内部控制自我评价报告' which translates to '2013 Annual Internal Control Self-Evaluation Report'. It discusses the company's internal control system, evaluation of its effectiveness, and compliance with relevant Chinese regulations and guidelines on internal control. The content includes detailed descriptions of internal control scope, standards for identifying control deficiencies, and the company's internal control execution and supervision mechanisms. It is a comprehensive report on internal control self-assessment rather than a general annual report or audit report. The document length is substantial (8973 characters), indicating it is the full report, not just an announcement. The nature of the document aligns with an Audit Report / Information (AR) category, as it focuses on internal control evaluation and audit-related information, excluding full annual financial statements. Therefore, the appropriate classification is AR with high confidence. FY 2013
2014-03-27 Chinese
2013年年度报告
Annual Report Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司 2013 年度报告全文" which translates to "Cachet Pharmaceutical Co., Ltd. 2013 Annual Report Full Text." It contains detailed financial data, accounting policies, management discussion, business overview, financial statements, and other comprehensive information typical of a full annual report. The document covers the fiscal year from January 1, 2013, to December 31, 2013, and includes sections such as company overview, financial data and indicators, board of directors report, risk disclosures, and detailed financial analysis. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2013
2014-03-27 Chinese
第四届监事会第八次会议决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of resolutions passed at the eighth meeting of the fourth Supervisory Board of 嘉事堂药业股份有限公司. It includes approvals of various reports such as the 2013 Supervisory Board Work Report, 2013 Internal Control Self-Evaluation Report, 2013 Profit Distribution Plan, 2013 Annual Report and its summary, and the 2013 Fundraising Use Report. The document is a formal announcement of these approvals and voting results, not the reports themselves. The document length is short (1492 characters), and it serves as a notice of meeting resolutions and voting outcomes rather than containing full financial statements or detailed report content. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2014-03-27 Chinese
内部控制缺陷认定标准
Governance Information Classification · 95% confidence The document is a detailed internal control deficiency recognition standard issued by a company, 嘉事堂药业股份有限公司, dated March 26, 2014. It outlines quantitative and qualitative criteria for identifying internal control deficiencies related to financial reporting and non-financial reporting. The content focuses on internal control standards and risk management rather than financial results, audit opinions, or regulatory announcements. It does not contain financial statements or audit reports but rather internal governance and control guidelines. This type of document aligns best with Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2014-03-27 Chinese
内部控制规则落实自查表
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to audit committee operations, information disclosure, insider trading controls, fundraising, related party transactions, external guarantees, major investments, and other important matters. The document is a self-assessment or internal control checklist rather than a formal audit report or annual report. It does not contain financial statements or management discussion and analysis. It is not a certification or a brief announcement but a detailed internal control compliance document. This type of document aligns best with an Audit Report / Information (AR) category, which includes standalone audit reports and internal control results, excluding full annual reports. The document length is 3302 characters, which is relatively short but contains substantive internal control information, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2013
2014-03-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.